Matthew G. Lackemeyer Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health (NIH) Biography Publications Institution JoVE Articles Matthew G. Lackemeyer has not added a biography. If you are Matthew G. Lackemeyer and would like to personalize this page please email our Author Liaison for assistance. Publications Exposure of Rhesus Monkeys to Cowpox Virus Brighton Red by Large-particle Aerosol Droplets Results in an Upper Respiratory Tract Disease The Journal of General Virology. Aug, 2016 | Pubmed ID: 27166137 Influenza A and Methicillin-resistant Staphylococcus Aureus Co-infection in Rhesus Macaques - A Model of Severe Pneumonia Antiviral Research. May, 2016 | Pubmed ID: 26923881 Reorganization and Expansion of the Nidoviral Family Arteriviridae Archives of Virology. Mar, 2016 | Pubmed ID: 26608064 Historical Outbreaks of Simian Hemorrhagic Fever in Captive Macaques Were Caused by Distinct Arteriviruses Journal of Virology. Aug, 2015 | Pubmed ID: 25972539 Generation and Characterization of Large-particle Aerosols Using a Center Flow Tangential Aerosol Generator with a Non-human-primate, Head-only Aerosol Chamber Inhalation Toxicology. 2015 | Pubmed ID: 25970823 Small Particle Aerosol Inoculation of Cowpox Brighton Red in Rhesus Monkeys Results in a Severe Respiratory Disease Virology. Jul, 2015 | Pubmed ID: 25776759 Simian Hemorrhagic Fever Virus Cell Entry is Dependent on CD163 and Uses a Clathrin-mediated Endocytosis-like Pathway Journal of Virology. Jan, 2015 | Pubmed ID: 25355889 Genome Sequences of Simian Hemorrhagic Fever Virus Variant NIH LVR42-0/M6941 Isolates (Arteriviridae: Arterivirus) Genome Announcements. 2014 | Pubmed ID: 25301647 Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names Viruses. Sep, 2014 | Pubmed ID: 25256396 The NIAID Integrated Research Facility at Frederick, Maryland: a Unique International Resource to Facilitate Medical Countermeasure Development for BSL-4 Pathogens Pathogens and Disease. Jul, 2014 | Pubmed ID: 24687975 ABSL-4 Aerobiology Biosafety and Technology at the NIH/NIAID Integrated Research Facility at Fort Detrick Viruses. Jan, 2014 | Pubmed ID: 24402304 Virus Nomenclature Below the Species Level: a Standardized Nomenclature for Filovirus Strains and Variants Rescued from CDNA Archives of Virology. May, 2014 | Pubmed ID: 24190508 The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters PloS One. 2013 | Pubmed ID: 23844250 Virus Nomenclature Below the Species Level: a Standardized Nomenclature for Laboratory Animal-adapted Strains and Variants of Viruses Assigned to the Family Filoviridae Archives of Virology. Jun, 2013 | Pubmed ID: 23358612 Aerosol Exposure to Zaire Ebolavirus in Three Nonhuman Primate Species: Differences in Disease Course and Clinical Pathology Microbes and Infection / Institut Pasteur. Oct, 2011 | Pubmed ID: 21651988 Severe Encephalitis in Cynomolgus Macaques Exposed to Aerosolized Eastern Equine Encephalitis Virus The Journal of Infectious Diseases. Aug, 2007 | Pubmed ID: 17597459 Aerosol Exposure to Western Equine Encephalitis Virus Causes Fever and Encephalitis in Cynomolgus Macaques The Journal of Infectious Diseases. Oct, 2005 | Pubmed ID: 16136459 Genetically Engineered, Live, Attenuated Vaccines Protect Nonhuman Primates Against Aerosol Challenge with a Virulent IE Strain of Venezuelan Equine Encephalitis Virus Vaccine. May, 2005 | Pubmed ID: 15837213 Misure di sicurezza e procedure operative in un (A) laboratorio BSL-4: 2. Pratiche generali Steven Mazur1, Michael R. Holbrook1, Tracey Burdette1, Nicole Josleyn1, Jason Barr1, Daniela Pusl1, Laura Bollinger1, Linda Coe1, Peter B. Jahrling1, Matthew G. Lackemeyer1, Jiro Wada1, Jens H. Kuhn1, Krisztina Janosko1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Immunologia e infezioni Misure di sicurezza e procedure operative in un (A) BSL-4 di laboratorio: 1. livello di biosicurezza 4 Suit Laboratorio Suite entrata e di uscita Procedure Krisztina Janosko1, Michael R. Holbrook1, Ricky Adams1, Jason Barr1, Laura Bollinger1, Je T'aime Newton2, Corrie Ntiforo2, Linda Coe1, Jiro Wada1, Daniela Pusl1, Peter B. Jahrling1, Jens H. Kuhn1, Matthew G. Lackemeyer1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), 2Environmental Health and Safety, Biological and Chemical Safety Program, University of Texas Medical Branch Immunologia e infezioni Misure di sicurezza e procedure operative in un (A) BSL-4 di laboratorio: 4. procedure di imaging medico Russell Byrum1, Lauren Keith1, Christopher Bartos1, Marisa St. Claire1, Matthew G. Lackemeyer1, Michael R. Holbrook1, Krisztina Janosko1, Jason Barr1, Daniela Pusl1, Laura Bollinger1, Jiro Wada1, Linda Coe1, Lisa E. Hensley1, Peter B. Jahrling1, Jens H. Kuhn1, Margaret R. Lentz1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Immunologia e infezioni Misure di sicurezza e procedure operative in un (A) BSL-4 di laboratorio: 3. aerobiologia J. Kyle Bohannon1, Krisztina Janosko1, Michael R. Holbrook1, Jason Barr1, Daniela Pusl1, Laura Bollinger1, Linda Coe1, Lisa E. Hensley1, Peter B. Jahrling1, Jiro Wada1, Jens H. Kuhn1, Matthew G. Lackemeyer1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Immunologia e infezioni
Misure di sicurezza e procedure operative in un (A) laboratorio BSL-4: 2. Pratiche generali Steven Mazur1, Michael R. Holbrook1, Tracey Burdette1, Nicole Josleyn1, Jason Barr1, Daniela Pusl1, Laura Bollinger1, Linda Coe1, Peter B. Jahrling1, Matthew G. Lackemeyer1, Jiro Wada1, Jens H. Kuhn1, Krisztina Janosko1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Immunologia e infezioni
Misure di sicurezza e procedure operative in un (A) BSL-4 di laboratorio: 1. livello di biosicurezza 4 Suit Laboratorio Suite entrata e di uscita Procedure Krisztina Janosko1, Michael R. Holbrook1, Ricky Adams1, Jason Barr1, Laura Bollinger1, Je T'aime Newton2, Corrie Ntiforo2, Linda Coe1, Jiro Wada1, Daniela Pusl1, Peter B. Jahrling1, Jens H. Kuhn1, Matthew G. Lackemeyer1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), 2Environmental Health and Safety, Biological and Chemical Safety Program, University of Texas Medical Branch Immunologia e infezioni
Misure di sicurezza e procedure operative in un (A) BSL-4 di laboratorio: 4. procedure di imaging medico Russell Byrum1, Lauren Keith1, Christopher Bartos1, Marisa St. Claire1, Matthew G. Lackemeyer1, Michael R. Holbrook1, Krisztina Janosko1, Jason Barr1, Daniela Pusl1, Laura Bollinger1, Jiro Wada1, Linda Coe1, Lisa E. Hensley1, Peter B. Jahrling1, Jens H. Kuhn1, Margaret R. Lentz1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Immunologia e infezioni
Misure di sicurezza e procedure operative in un (A) BSL-4 di laboratorio: 3. aerobiologia J. Kyle Bohannon1, Krisztina Janosko1, Michael R. Holbrook1, Jason Barr1, Daniela Pusl1, Laura Bollinger1, Linda Coe1, Lisa E. Hensley1, Peter B. Jahrling1, Jiro Wada1, Jens H. Kuhn1, Matthew G. Lackemeyer1 1Integrated Research Facility at Frederick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Immunologia e infezioni